A 50-year-old with T2DM, obesity, and NAFLD (steatosis) has A1C 7.8% on metformin. Which agent provides glycemic control and weight reduction with liv...

Question

A 50-year-old with T2DM, obesity, and NAFLD (steatosis) has A1C 7.8% on metformin. Which agent provides glycemic control and weight reduction with liver benefit?

Accepted Answer

GLP-1 receptor agonist

Answer

Sulfonylurea

Answer

Basal insulin

Answer

Pioglitazone

Answer

DPP-4 inhibitor

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes Mellitus

A 50-year-old with T2DM, obesity, and NAFLD (steatosis) has A1C 7.8% on metformin. Which agent provides glycemic control and weight reduction with liver benefit?